Hims Hers shares rally on results, but execs say GLP1 drug shortage ‘is not abating’
Nov 04, 2024
Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales forecast higher, as its efforts to offer more personalized care and more weight-loss drugs continue to draw subscribers.
https://www.marketwatch.com/story/hims-hers-shares-rally-on-results-but-execs-say-glp-1-drug-shortage-is-not-abating-5342ebd0?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service